Overdose or immediate danger? Call 911 · In crisis? Call or text 988 · SAMHSA Helpline: 1-800-662-4357 · Text HOME to 741741

"Gas Station Heroin" — The substances hiding in plain sight

7-OH (7-hydroxymitragynine) is an opioid. It occurs naturally in only trace amounts in the kratom plant. The concentrated 7-OH in shots, gummies, and tablets sold at gas stations and smoke shops is most likely made by chemically converting mitragynine, kratom's main alkaloid, according to the FDA. It acts on the same brain receptors as morphine, and daily use can lead to dependence, with opioid withdrawal when you stop.

Walk into almost any gas station, smoke shop, or convenience store in America and you'll find colorful shots, gummies, and capsules marketed as natural relaxants, mood boosters, or botanical supplements. Several of these products contain powerfully addictive — and in some cases deadly — substances, often sold openly, even in states that restrict them. This is not a fringe problem. It is a national public health crisis that most people have never heard of.

⚠ The three substances driving this crisis

  • 7-OH (7-hydroxymitragynine) / Kratom Extracts — concentrated opioid sold as a "botanical supplement"
  • Tianeptine — also sold as ZaZa, TD Red, Neptune's Fix — an opioid-acting antidepressant never approved by the FDA, proposed for federal Schedule I in July 2026, and still sold as a supplement where state law allows
  • Xylazine (Tranq) — a veterinary sedative now contaminating the street fentanyl supply — not reversed by Narcan

ZaZa is a brand name, not a separate drug. The FDA lists it among tianeptine products. Check the ingredient label on anything sold under that name.

🔴 7-OH and Kratom Extracts

7-hydroxymitragynine (7-OH) is a compound derived from kratom, a plant native to Southeast Asia. While traditional kratom leaf has been used for generations at low doses, manufacturers now sell concentrated 7-OH in shots, gummies, and capsules far stronger than kratom leaf. The result is a cheap, widely available opioid that sidesteps the safeguards around prescription pain medications. It is sold without a prescription, and sometimes in violation of state law.

🏪

Where it's sold

Gas stations, smoke shops, vape stores, convenience stores, and online. Often displayed near the register. Brand names change constantly. Look for “7-OH” or “7-hydroxymitragynine” on the label.

🎯

Who it's marketed to

People with chronic pain seeking a "natural" alternative to opioids. People trying to manage opioid withdrawal on their own. Workers seeking energy boosts. Athletes. Anyone with anxiety looking for relief. The marketing deliberately targets vulnerable people.

💊

What it looks like

2-oz liquid shots resembling energy drinks, gummies, capsules, powders. Packaging uses leaves, mountains, and wellness imagery. 7-OH content is rarely clearly labeled. Age limits depend on the state. Florida, for example, bans selling any kratom product, including extracts, to anyone under 21. Enforcement varies, and the FDA warns that kids can buy 7-OH products at gas stations and convenience stores.

🧠

Effects & side effects

At low doses: mild stimulation, mood lift, pain relief. At higher doses: sedation, euphoria identical to opioids. Side effects: nausea, constipation, dizziness, liver stress. With regular use: tolerance builds rapidly, and dependence can develop with regular daily use.

⚖️

Is it legal where you live?

Kratom and 7-OH laws differ by state and are changing fast. Florida controls concentrated 7-OH products under a state emergency rule, and Rhode Island now licenses kratom sales while banning synthetic 7-OH. Check your state's current law.

Federal: on August 26, 2026 the DEA placed three 7-OH-related synthetics (mitragynine pseudoindoxyl, MGM-15, and MGM-16) in Schedule I. In July 2026 the DEA announced it intends to temporarily place 7-OH above a set threshold in Schedule I; HHS took public comments on that threshold through September 10, 2026. As of September 28, 2026, no order for 7-OH itself has been published. When it is, it takes effect the day it publishes.

🩺

Getting help

7-OH withdrawal is medically significant. Addiction medicine clinicians are treating 7-OH dependence with buprenorphine (Suboxone), the same medication used for opioid use disorder. Early case reports are encouraging; there are no clinical trials yet. Do not stop abruptly. Tell your doctor exactly what you've been taking and how much. We wrote the full day-by-day timeline: what 7-OH withdrawal actually feels like.

Signs of 7-OH dependence Using every day to feel normal · Needing more to get the same effect · Sweating, muscle aches, vomiting, anxiety when you skip a dose · These are opioid withdrawal symptoms — here's the day-by-day timeline. Call SAMHSA: 1-800-662-4357

🟡 Tianeptine — ZaZa, TD Red, Neptune's Fix, Tianna

Tianeptine is a pharmaceutical antidepressant approved in some European and Asian countries — but never approved by the FDA in the United States. That hasn't stopped manufacturers from marketing it as a "dietary supplement" at gas stations, smoke shops, and online. It is one of the most misunderstood and dangerous substances in the gas station drug category.

At prescribed therapeutic doses, tianeptine acts on serotonin. At the high doses people are typically taking for recreational or self-medication purposes, it acts powerfully on opioid receptors — producing euphoria and sedation nearly indistinguishable from opioid drugs. Dependence can develop within weeks. The withdrawal is severe.

🏷️

Brand names to know

ZaZa Red, ZaZa Silver, TD Red, Neptune's Fix, Tianna, Stablon (pharmaceutical name). Often sold as a "dietary supplement" or "nootropic." Packaging looks legitimate and wellness-oriented.

⚡

Why it's dangerous

Opioid-level dependence develops quickly. High doses cause intense euphoria followed by deep sedation. Overdose risk increases sharply with higher doses. When mixed with alcohol or other CNS depressants, it can stop breathing.

😰

Withdrawal

Severe: extreme anxiety, vomiting, muscle cramps, cold sweats, suicidal ideation. Withdrawal begins within hours of last dose and can last weeks. Medical supervision is strongly recommended.

🗺️

Legal status

Tianeptine is a controlled substance in a growing number of states, including Florida, where it is Schedule I. The FDA has warned consumers not to use it. State laws change often; check yours.

If you are using tianeptine / ZaZa daily Do not stop without medical support. Tianeptine withdrawal can be life-threatening. Go to an urgent care or emergency room and tell them exactly what you're taking. Opioid withdrawal protocols apply.

🔴 Xylazine — "Tranq," "Tranq Dope," the Narcan-Resistant Crisis

Xylazine is a veterinary sedative used to anesthetize large animals like horses and cattle. It has no approved medical use in humans. It is not a federally controlled substance, but Florida and other states have made illicit xylazine illegal. And it is now found in the illicit fentanyl supply across most of the United States — mixed in by drug traffickers to extend the duration of the high and increase the weight of the product.

⚠ Critical: Narcan does NOT reverse xylazine

  • Xylazine is not an opioid — naloxone (Narcan) has no effect on it
  • When xylazine is mixed with fentanyl, Narcan may reverse the opioid component — but the person may remain unresponsive from xylazine
  • Call 911 every time, right after you give Narcan. Xylazine can keep someone sedated even after Narcan works on the opioid, so do not assume the overdose is over
  • Xylazine causes severe skin wounds — necrotic lesions that can require amputation — including on parts of the body away from where someone injected
  • In 2023 the White House designated fentanyl adulterated or associated with xylazine an "emerging threat"
🗺️

Where it's showing up

Initially concentrated in Philadelphia and the Northeast, xylazine/fentanyl ("tranq dope") has spread to every region of the country, with some of the fastest recent increases in the South and West. People are often unaware they are using it — it is mixed into street drugs without the user's knowledge.

💉

What it does

Deepens and extends sedation beyond what fentanyl produces alone. Naloxone (Narcan) does not reverse the xylazine part of an overdose. Produces distinctive skin wounds — open sores and necrotic lesions — even in non-injection areas. Researchers are still working out exactly why.

🩹

The wound crisis

"Tranq wounds" — severe, often infected skin ulcers — are appearing in people who use street drugs, often away from injection sites. Some clinicians report them even in people who smoke or snort rather than inject. These wounds can become infected, spread to bone, and in severe cases require amputation. Wound care is now a major part of xylazine harm reduction.

🆘

If someone overdoses on tranq dope

Administer Narcan — it will address the opioid component. But continue rescue breathing. Call 911 regardless of whether they respond to Narcan. Xylazine sedation requires emergency medical support that naloxone cannot provide.


The storm coming

The U.S. is only beginning to see the full consequences of gas station drugs. These substances are sold legally, packaged to look harmless, marketed aggressively to people in pain, and purchased by people who don't know they're using an opioid-equivalent. Many first-time users have no prior history with controlled substances.

States are starting to act — tianeptine has been banned in several states, kratom legislation is moving — but federal regulation has been slow, and the industry is large, profitable, and litigious. Public awareness is the most powerful tool available right now.

If you or someone you know regularly uses any product from a gas station or smoke shop that is supposed to make you feel calm, euphoric, or pain-free — please read the information above and talk to a doctor. You may be more dependent than you know.

Get help now SAMHSA National Helpline: 1-800-662-4357 — free, confidential, 24/7. They can connect you with a provider who understands these substances and what treatment looks like.

Sources

  1. 7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat. U.S. Food and Drug Administration, July 2025.
  2. Hiding in Plain Sight: 7-OH Products. U.S. Food and Drug Administration, updated July 13, 2026.
  3. Preventing the Next Wave of the Opioid Epidemic: What You Need to Know About 7-OH. U.S. Food and Drug Administration, July 2025.
  4. Notice of intent: temporary placement of 7-hydroxymitragynine above a specified threshold in Schedule I. Drug Enforcement Administration, Federal Register 2026-13580, July 6, 2026.
  5. Request for information on the proposed 7-OH threshold. U.S. Department of Health and Human Services, Federal Register 2026-13608, July 6, 2026.
  6. 7-OH threshold: extension of comment period to September 10, 2026. U.S. Department of Health and Human Services, Federal Register 2026-17409, August 26, 2026.
  7. Temporary order: mitragynine pseudoindoxyl, MGM-15, and MGM-16 in Schedule I. Drug Enforcement Administration, Federal Register 2026-17429, August 26, 2026.
  8. Buprenorphine for the Management of 7-Hydroxymitragynine (7-OH) Use: A Retrospective Case Series. Fenske E, et al., Journal of Addiction Medicine, 2026.
  9. Attorney General signs emergency rule scheduling concentrated 7-OH and related compounds. Florida Office of the Attorney General, June 22, 2026.
  10. Fla. Stat. § 893.035, Control of new substances (temporary scheduling by the Attorney General). Florida Legislature, 2026.
  11. Fla. Stat. § 500.92, Florida Kratom Consumer Protection Act (no sales under 21). Florida Legislature, 2026.
  12. R.I. Gen. Laws § 21-28.12-3, Rhode Island Kratom Act: kratom product limitations. Rhode Island General Assembly, effective April 1, 2026.
  13. FDA warns consumers not to purchase or use any tianeptine product due to serious risks. U.S. Food and Drug Administration, updated May 8, 2025.
  14. Proposed rule: placement of tianeptine in Schedule I. Drug Enforcement Administration, Federal Register 2026-13821, July 8, 2026.
  15. Fla. Stat. § 893.03, Standards and schedules (tianeptine and xylazine in Schedule I). Florida Legislature, 2026.
  16. Fentanyl combined with xylazine designated an emerging threat. White House Office of National Drug Control Policy, April 12, 2023.
  17. Xylazine. National Institute on Drug Abuse, accessed September 28, 2026.
  18. FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs. U.S. Food and Drug Administration, November 8, 2022.
  19. Surgical Challenges and Harm-reduction Strategies in Xylazine-associated Wounds: A Systematic Review. Kastury MR, et al., Plastic and Reconstructive Surgery Global Open, 2026.
  20. SAMHSA Overdose Prevention and Response Toolkit (PEP23-03-00-001). Substance Abuse and Mental Health Services Administration, 2026.
↑